Evidence map›Paper›PMID 29771360›Full record

ArticleJournal of the Pediatric Infectious Diseases Society2019

Patient and Treatment Characteristics by Infecting Organism in Cerebrospinal Fluid Shunt Infection.

Tamara D Simon, Matthew P Kronman, Kathryn B Whitlock, Samuel R Browd, Richard Holubkov, John R W Kestle, Abhaya V Kulkarni, Marcie Langley, David D Limbrick, Thomas G Luerssen and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the Pediatric Infectious Diseases Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Infection and immunity · 2021
    Article
  9. Infection and immunity · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 2 countries.

Tamara D SimonDepartment of Pediatrics, University of Washington/Seattle Children's Hospital, Washington.
Matthew P KronmanDepartment of Pediatrics, University of Washington/Seattle Children's Hospital, Washington.
Kathryn B WhitlockSeattle Children's Research Institute, Washington.
Samuel R BrowdDepartment of Neurosurgery, University of Washington/Seattle Children's Hospital, Washington.
Richard HolubkovDepartment of Pediatrics, University of Utah, Salt Lake City.
John R W KestleDivision of Pediatric Neurosurgery, Department of Neurosurgery, University of Utah, Salt Lake City.
Abhaya V KulkarniDivision of Neurosurgery, Hospital for Sick Children, University of Toronto, Canada.
Marcie LangleyDivision of Pediatric Neurosurgery, Department of Neurosurgery, University of Utah, Salt Lake City.
David D LimbrickDepartment of Neurosurgery, St. Louis Children's Hospital, Washington University in St. Louis, Missouri.
Thomas G LuerssenDivision of Pediatric Neurosurgery, Texas Children's Hospital, Department of Neurosurgery, Baylor College of Medicine, Houston.
Jerry OakesSection of Pediatric Neurosurgery, Children's Hospital of Alabama, Division of Neurosurgery, University of Alabama - Birmingham.
Jay Riva-CambrinDivision of Pediatric Neurosurgery, Department of Neurosurgery, University of Utah, Salt Lake City.
Curtis RozzelleSection of Pediatric Neurosurgery, Children's Hospital of Alabama, Division of Neurosurgery, University of Alabama - Birmingham.
Chevis N ShannonSection of Pediatric Neurosurgery, Children's Hospital of Alabama, Division of Neurosurgery, University of Alabama - Birmingham.
Mandeep TamberDivision of Neurosurgery, Children's Hospital of Pittsburgh, Pennsylvania.
John C Wellons IiiSection of Pediatric Neurosurgery, Children's Hospital of Alabama, Division of Neurosurgery, University of Alabama - Birmingham.
William E WhiteheadDivision of Pediatric Neurosurgery, Texas Children's Hospital, Department of Neurosurgery, Baylor College of Medicine, Houston.
Nicole Mayer-HamblettDepartment of Pediatrics, University of Washington/Seattle Children's Hospital, Washington.
Hydrocephalus Clinical Research Network
University of Utah · USBaylor College of Medicine · USChildren's of Alabama · USSeattle Children's Hospital · USUniversity of Alabama · USUniversity of Washington · USChildren's Hospital of Pittsburgh · USSickKids Foundation · CAWashington University in St. Louis · US

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
INSTITUTE FOR TRANSLATIONAL HEALTH SCIENCE (UL1): BPCAUL1RR025014 · NCRR · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2007 to 2011
$51.5M
Hydrocephalus Clinical Research Network: a consortium for pediatric hydrocephalusRC1NS068943 · NINDS · UNIVERSITY OF UTAH · PI KESTLE, JOHN · 2009 to 2010
$995k
Multi-center Studies of Pediatric CSF Shunt InfectionsK23NS062900 · NINDS · UNIVERSITY OF UTAH · PI SIMON, TAMARA DANIELLE · 2009 to 2013
$893k
NCATS NIH HHS UL1 TR002319NCRR NIH HHS UL1 RR025014NINDS NIH HHS K23 NS062900NINDS NIH HHS RC1 NS068943
6 · The paper itself

Abstract

backgroundPrevious studies of cerebrospinal fluid (CSF) shunt infection treatment have been limited in size and unable to compare patient and treatment characteristics by infecting organism. Our objective was to describe variation in patient and treatment characteristics for children with first CSF shunt infection, stratified by infecting organism subgroups outlined in the 2017 Infectious Disease Society of America's (IDSA) guidelines.

methodsWe studied a prospective cohort of children <18 years of age undergoing treatment for first CSF shunt infection at one of 7 Hydrocephalus Clinical Research Network hospitals from April 2008 to December 2012. Differences between infecting organism subgroups were described using univariate analyses and Fisher's exact tests.

resultsThere were 145 children whose infections were diagnosed by CSF culture and addressed by IDSA guidelines, including 47 with Staphylococcus aureus, 52 with coagulase-negative Staphylococcus, 37 with Gram-negative bacilli, and 9 with Propionibacterium acnes. No differences in many patient and treatment characteristics were seen between infecting organism subgroups, including age at initial shunt, gender, race, insurance, indication for shunt, gastrostomy, tracheostomy, ultrasound, and/or endoscope use at all surgeries before infection, or numbers of revisions before infection. A larger proportion of infections were caused by Gram-negative bacilli when antibiotic-impregnated catheters were used at initial shunt placement (12 of 23, 52%) and/or subsequent revisions (11 of 23, 48%) compared with all other infections (9 of 68 [13%] and 13 of 68 [19%], respectively). No differences in reinfection were observed between infecting organism subgroups.

conclusionsThe organism profile encountered at infection differs when antibiotic-impregnated catheters are used, with a higher proportion of Gram-negative bacilli. This warrants further investigation given increasing adoption of antibiotic-impregnated catheters.

Indexed as

Anti-Bacterial AgentsBacterial InfectionsCerebrospinal Fluid ShuntsFemaleHumansHydrocephalusInfantInfant, NewbornMalePropionibacterium acnesProspective StudiesRisk FactorsStaphylococcal InfectionsStaphylococcus aureusAnti-Bacterial Agentsantibioticantibiotic-impregnated cathetercerebrospinalinfectionshunt

Identifiers

PMID29771360
PMCPMC6601384
OpenAlexW2804865227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.